DYN
Price
$8.76
Change
-$0.18 (-2.01%)
Updated
Jul 3 closing price
Capitalization
1.24B
25 days until earnings call
IOBT
Price
$1.49
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
98.16M
33 days until earnings call
Interact to see
Advertisement

DYN vs IOBT

Header iconDYN vs IOBT Comparison
Open Charts DYN vs IOBTBanner chart's image
Dyne Therapeutics
Price$8.76
Change-$0.18 (-2.01%)
Volume$1.99M
Capitalization1.24B
IO Biotech
Price$1.49
Change-$0.00 (-0.00%)
Volume$182.87K
Capitalization98.16M
DYN vs IOBT Comparison Chart in %
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. IOBT commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a StrongBuy and IOBT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (DYN: $8.76 vs. IOBT: $1.49)
Brand notoriety: DYN and IOBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 72% vs. IOBT: 112%
Market capitalization -- DYN: $1.24B vs. IOBT: $98.16M
DYN [@Biotechnology] is valued at $1.24B. IOBT’s [@Biotechnology] market capitalization is $98.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileIOBT’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • IOBT’s FA Score: 0 green, 5 red.
According to our system of comparison, IOBT is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 5 TA indicator(s) are bullish while IOBT’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 5 bullish, 5 bearish.
  • IOBT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DYN is a better buy in the short-term than IOBT.

Price Growth

DYN (@Biotechnology) experienced а -12.84% price change this week, while IOBT (@Biotechnology) price change was +0.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

DYN is expected to report earnings on Oct 30, 2025.

IOBT is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.24B) has a higher market cap than IOBT($98.2M). IOBT YTD gains are higher at: 61.957 vs. DYN (-62.818). IOBT has higher annual earnings (EBITDA): -96.7M vs. DYN (-395.31M). DYN has more cash in the bank: 677M vs. IOBT (37.1M). IOBT has less debt than DYN: IOBT (1.76M) vs DYN (23.3M). DYN (0) and IOBT (0) have equivalent revenues.
DYNIOBTDYN / IOBT
Capitalization1.24B98.2M1,263%
EBITDA-395.31M-96.7M409%
Gain YTD-62.81861.957-101%
P/E RatioN/AN/A-
Revenue00-
Total Cash677M37.1M1,825%
Total Debt23.3M1.76M1,322%
TECHNICAL ANALYSIS
Technical Analysis
DYNIOBT
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend about 1 month ago
85%
Bullish Trend 12 days ago
90%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 5 days ago
87%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FMCC7.980.02
+0.25%
Freddie Mac
AMLLF18.10N/A
N/A
Aeon Mall Co., Ltd.
BBSEY6.80N/A
N/A
BB Seguridade Participacoes SA
PNBI25.83N/A
N/A
Pioneer Bankshares, Inc.
KICK8.75N/A
N/A
HPN Holdings, Inc.

IOBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBT has been loosely correlated with DYN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IOBT jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBT
1D Price
Change %
IOBT100%
N/A
DYN - IOBT
35%
Loosely correlated
-2.01%
GLMD - IOBT
34%
Loosely correlated
+0.83%
RNA - IOBT
31%
Poorly correlated
-0.65%
RGNX - IOBT
31%
Poorly correlated
+1.39%
OCGN - IOBT
29%
Poorly correlated
+3.30%
More